Kyowa Kirin
4151.TPharmaceutical
Filed as Kyowa Kirin Co., Ltd. (2022-08–2026-08)
Financials · Standalone
| Fiscal year ended | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|---|
| Revenue | ¥297.3bn | ¥286.5bn | ¥277.2bn | ¥253.8bn | ¥237.6bn | ¥252.9bn |
| Operating income | ¥60.0bn | −¥4.6bn | ¥53.4bn | ¥40.6bn | ¥24.8bn | — |
| Ordinary income | ¥56.9bn | ¥68.6bn | ¥67.2bn | ¥37.3bn | ¥35.2bn | ¥49.6bn |
| Total assets | ¥808.5bn | ¥797.9bn | ¥869.6bn | ¥806.1bn | ¥794.1bn | ¥687.7bn |
| Net assets / equity | ¥614.9bn | ¥613.0bn | ¥622.7bn | ¥601.9bn | ¥596.9bn | ¥555.7bn |
| EPS (basic) | ¥61.97 | ¥114.57 | ¥93.7 | ¥57.77 | ¥123.52 | ¥58.18 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 13
| Period | Form | Figures |
|---|---|---|
| 2026-01-01 → 2026-06-30 | Half-year | 76 figures · EDINET |
| 2025-01-01 → 2025-12-31 | Annual | 209 figures · EDINET |
| 2025-01-01 → 2025-06-30 | Half-year | 78 figures · EDINET |
| 2024-01-01 → 2024-12-31 | Annual | 209 figures · EDINET |
| 2024-01-01 → 2024-06-30 | Half-year | 92 figures · EDINET |
| 2024-01-01 → 2024-03-31 | Quarterly Q1 | 78 figures · EDINET |
| 2023-01-01 → 2023-12-31 | Annual | 209 figures · EDINET |
| 2023-01-01 → 2023-09-30 | Quarterly Q3 | 98 figures · EDINET |
| 2023-01-01 → 2023-06-30 | Quarterly Q2 | 96 figures · EDINET |
| 2023-01-01 → 2023-03-31 | Quarterly Q1 | 76 figures · EDINET |
| 2022-01-01 → 2022-12-31 | Annual | 209 figures · EDINET |
| 2022-01-01 → 2022-09-30 | Quarterly Q3 | 98 figures · EDINET |
| 2022-01-01 → 2022-06-30 | Quarterly Q2 | 98 figures · EDINET |
23 more reports are still being processed.